Orbimed Advisors - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 49 filers reported holding VOR BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2022$445,000
-89.3%
111,808
-86.6%
0.01%
-89.3%
Q2 2022$4,142,000
-17.7%
833,3330.0%0.08%
-8.5%
Q1 2022$5,033,000
-48.0%
833,3330.0%0.08%
-33.9%
Q4 2021$9,683,000
-25.9%
833,3330.0%0.12%
-13.9%
Q3 2021$13,067,000
-15.9%
833,3330.0%0.14%
-8.3%
Q2 2021$15,542,000
-56.7%
833,3330.0%0.16%
-53.3%
Q1 2021$35,917,000833,3330.34%
Other shareholders
VOR BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,692,429$124,814,00031.41%
Trustees of Columbia University in the City of New York 183,821$3,428,0005.06%
RA Capital Management 11,120,973$207,406,0003.33%
Johnson & Johnson Innovation - JJDC, Inc. 1,074,658$20,042,0002.05%
Sarissa Capital Management LP 707,010$13,186,0001.05%
SECTORAL ASSET MANAGEMENT INC 405,324$7,559,0000.61%
Woodline Partners LP 1,146,494$21,382,0000.40%
Artal Group S.A. 550,000$10,258,0000.21%
NEXPOINT ASSET MANAGEMENT, L.P. 50,000$933,0000.20%
Orbimed Advisors 833,333$15,542,0000.16%
View complete list of VOR BIOPHARMA INC shareholders